Oramed Pharm's market cap is currently $117.42M. The company's EPS TTM is $1.131; its P/E ratio is 2.94; Oramed Pharm is scheduled to report earnings on November 17, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
